Consumer Staples • Retail-Drug Stores and Proprietary Stores
$0.83 ▼ -0.02
(-2.45%)
MKT CAP: $3.0M • VOL: 24.0K
52W L $1 52W H $761
ROARABLE / RQD
D- • 43/100
PIOTROSKI
1 / 9
RDGT // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2026-03-31 | FY 2024
FILED 2025-03-31 | FY 2023
FILED 2024-03-31 |
|---|---|---|---|
| Revenue (Total Sales) | $132.2M | $120.0M | $124.0M |
| YoY Revenue Growth % | +10.2% | -3.2% | — |
| Gross Profit | $4.8M | $3.8M | — |
| Gross Margin % | 3.6% | 3.2% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$1.9M | -$1.0M | $596.1K |
| Operating Margin % | -1.4% | -0.9% | 0.5% |
| Net Income (GAAP) | -$1.3M | $10.2M | -$4.2M |
| EBITDA (Normalized) | -$1.9M | -$911.1K | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$1.4M | $1.2M | -$3.2M |
| Capital Expenditures (CapEx) | $449 | $155.4K | — |
| Free Cash Flow (FCF) | -$1.4M | $1.1M | -$3.2M |
| FCF Margin % | -1.1% | 0.9% | -2.5% |
| Return on Invested Capital (ROIC %) | — | — | — |
| Cash & Short-Term Equivalents | — | — | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | — | — | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR RDGT.